Clinical Trial Update: VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating valsartan with supportive measures and its impact on medication adherence in adults with hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED